nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—PTGS2—ovarian follicle—polycystic ovary syndrome	0.0345	0.147	CbGeAlD
Phenylbutazone—SLC22A8—urine—polycystic ovary syndrome	0.0254	0.108	CbGeAlD
Phenylbutazone—PTGIS—uterus—polycystic ovary syndrome	0.0176	0.0748	CbGeAlD
Phenylbutazone—PTGIS—adipose tissue—polycystic ovary syndrome	0.0172	0.0731	CbGeAlD
Phenylbutazone—CYP2C9—urine—polycystic ovary syndrome	0.0165	0.0704	CbGeAlD
Phenylbutazone—PTGIS—adrenal gland—polycystic ovary syndrome	0.0154	0.0656	CbGeAlD
Phenylbutazone—PTGIS—female gonad—polycystic ovary syndrome	0.0144	0.0612	CbGeAlD
Phenylbutazone—PTGIS—endocrine gland—polycystic ovary syndrome	0.0134	0.0569	CbGeAlD
Phenylbutazone—CYP3A4—urine—polycystic ovary syndrome	0.0126	0.0537	CbGeAlD
Phenylbutazone—SLC22A11—endocrine gland—polycystic ovary syndrome	0.00748	0.0318	CbGeAlD
Phenylbutazone—PTGS2—embryo—polycystic ovary syndrome	0.00466	0.0199	CbGeAlD
Phenylbutazone—PTGS2—adrenal cortex—polycystic ovary syndrome	0.00382	0.0163	CbGeAlD
Phenylbutazone—Modafinil—ADRA1B—polycystic ovary syndrome	0.00364	0.218	CrCbGaD
Phenylbutazone—PTGS1—endometrium—polycystic ovary syndrome	0.00357	0.0152	CbGeAlD
Phenylbutazone—Phenoxybenzamine—ADRA1D—polycystic ovary syndrome	0.00353	0.212	CrCbGaD
Phenylbutazone—PTGS2—endometrium—polycystic ovary syndrome	0.00341	0.0145	CbGeAlD
Phenylbutazone—PTGS1—uterus—polycystic ovary syndrome	0.00329	0.014	CbGeAlD
Phenylbutazone—PTGS1—pituitary gland—polycystic ovary syndrome	0.00323	0.0138	CbGeAlD
Phenylbutazone—PTGS1—adipose tissue—polycystic ovary syndrome	0.00322	0.0137	CbGeAlD
Phenylbutazone—PTGS2—uterus—polycystic ovary syndrome	0.00315	0.0134	CbGeAlD
Phenylbutazone—PTGS2—pituitary gland—polycystic ovary syndrome	0.00309	0.0132	CbGeAlD
Phenylbutazone—PTGS2—adipose tissue—polycystic ovary syndrome	0.00308	0.0131	CbGeAlD
Phenylbutazone—Phenoxybenzamine—ADRA1B—polycystic ovary syndrome	0.00301	0.181	CrCbGaD
Phenylbutazone—PTGS1—adrenal gland—polycystic ovary syndrome	0.00289	0.0123	CbGeAlD
Phenylbutazone—PTGS2—adrenal gland—polycystic ovary syndrome	0.00276	0.0117	CbGeAlD
Phenylbutazone—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00274	0.0117	CbGeAlD
Phenylbutazone—PTGS1—female gonad—polycystic ovary syndrome	0.00269	0.0115	CbGeAlD
Phenylbutazone—PTGS1—vagina—polycystic ovary syndrome	0.00268	0.0114	CbGeAlD
Phenylbutazone—PTGS2—female gonad—polycystic ovary syndrome	0.00257	0.011	CbGeAlD
Phenylbutazone—PTGS2—vagina—polycystic ovary syndrome	0.00256	0.0109	CbGeAlD
Phenylbutazone—PTGS1—endocrine gland—polycystic ovary syndrome	0.0025	0.0107	CbGeAlD
Phenylbutazone—PTGS2—endocrine gland—polycystic ovary syndrome	0.00239	0.0102	CbGeAlD
Phenylbutazone—Benzphetamine—ADRA1A—polycystic ovary syndrome	0.00212	0.127	CrCbGaD
Phenylbutazone—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00209	0.0089	CbGeAlD
Phenylbutazone—Phenoxybenzamine—ADRA1A—polycystic ovary syndrome	0.00203	0.122	CrCbGaD
Phenylbutazone—Phenoxybenzamine—ADRB2—polycystic ovary syndrome	0.00121	0.0723	CrCbGaD
Phenylbutazone—Methadone—CYP19A1—polycystic ovary syndrome	0.00114	0.0682	CrCbGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000294	0.000393	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000291	0.000389	CbGpPWpGaD
Phenylbutazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00029	0.000388	CbGpPWpGaD
Phenylbutazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000288	0.000385	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000288	0.000385	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SUOX—polycystic ovary syndrome	0.000288	0.000385	CbGpPWpGaD
Phenylbutazone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000285	0.00038	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000285	0.00038	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000281	0.000376	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000279	0.000373	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—TH—polycystic ovary syndrome	0.00027	0.000361	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000269	0.000359	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000269	0.000359	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000269	0.000359	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000268	0.000358	CbGpPWpGaD
Phenylbutazone—PTGS1—Biological oxidations—POMC—polycystic ovary syndrome	0.000267	0.000357	CbGpPWpGaD
Phenylbutazone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000264	0.000353	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—SLC2A4—polycystic ovary syndrome	0.000263	0.000351	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000262	0.00035	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000262	0.00035	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000256	0.000341	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000253	0.000339	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—NCOR1—polycystic ovary syndrome	0.000251	0.000335	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000251	0.000335	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NMNAT3—polycystic ovary syndrome	0.00025	0.000334	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CYP19A1—polycystic ovary syndrome	0.000247	0.00033	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—NRG1—polycystic ovary syndrome	0.000246	0.000329	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000245	0.000327	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000239	0.000319	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000236	0.000316	CbGpPWpGaD
Phenylbutazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000234	0.000312	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000234	0.000312	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000233	0.000312	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000233	0.000312	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000233	0.000312	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000232	0.00031	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00023	0.000308	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000229	0.000306	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SUOX—polycystic ovary syndrome	0.000229	0.000306	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000228	0.000304	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—TEAD2—polycystic ovary syndrome	0.000228	0.000304	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000226	0.000302	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000225	0.000301	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MTHFR—polycystic ovary syndrome	0.000222	0.000296	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—GNAS—polycystic ovary syndrome	0.000221	0.000295	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000219	0.000293	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000216	0.000288	CbGpPWpGaD
Phenylbutazone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000215	0.000287	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000214	0.000287	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000214	0.000285	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000213	0.000285	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000213	0.000284	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IRS2—polycystic ovary syndrome	0.000211	0.000282	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—NCOR1—polycystic ovary syndrome	0.00021	0.000281	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000209	0.00028	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000208	0.000278	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000207	0.000276	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000204	0.000272	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CYP1A1—polycystic ovary syndrome	0.000199	0.000266	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000198	0.000265	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000195	0.000261	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000195	0.00026	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000194	0.000259	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000192	0.000257	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000191	0.000255	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000188	0.000252	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000188	0.000251	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—MTHFR—polycystic ovary syndrome	0.000186	0.000248	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000186	0.000248	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IRS1—polycystic ovary syndrome	0.000184	0.000246	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000184	0.000246	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000181	0.000242	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000181	0.000242	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—TEAD2—polycystic ovary syndrome	0.000181	0.000242	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000179	0.000239	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—INS—polycystic ovary syndrome	0.000176	0.000236	CbGpPWpGaD
Phenylbutazone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000174	0.000233	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000174	0.000232	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000173	0.000232	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—STAR—polycystic ovary syndrome	0.000173	0.000231	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000171	0.000229	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000171	0.000228	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—AKT2—polycystic ovary syndrome	0.000171	0.000228	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000166	0.000221	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000164	0.000219	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—SERPINE1—polycystic ovary syndrome	0.000162	0.000217	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000158	0.000211	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000158	0.00021	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000154	0.000206	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000154	0.000206	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—HMMR—polycystic ovary syndrome	0.000154	0.000206	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—RPL37A—polycystic ovary syndrome	0.000154	0.000206	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000152	0.000203	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000152	0.000203	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000152	0.000202	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000152	0.000202	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PPARG—polycystic ovary syndrome	0.000151	0.000201	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00015	0.0002	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—POMC—polycystic ovary syndrome	0.000149	0.000199	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—INS—polycystic ovary syndrome	0.000148	0.000197	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000147	0.000196	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HMMR—polycystic ovary syndrome	0.000146	0.000195	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000145	0.000194	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000144	0.000192	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000141	0.000188	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.00014	0.000188	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000138	0.000184	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000138	0.000184	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—STAR—polycystic ovary syndrome	0.000137	0.000183	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000136	0.000181	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—LHB—polycystic ovary syndrome	0.000134	0.000179	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000131	0.000175	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000129	0.000172	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000127	0.000169	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000125	0.000166	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000124	0.000166	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000123	0.000164	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000123	0.000164	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	0.000122	0.000163	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000122	0.000163	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	0.00012	0.000161	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.00012	0.00016	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.00012	0.00016	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000117	0.000156	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000117	0.000156	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000115	0.000154	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000115	0.000154	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000113	0.000151	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—RRM2—polycystic ovary syndrome	0.000113	0.000151	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FGF18—polycystic ovary syndrome	0.000112	0.000149	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—RBP4—polycystic ovary syndrome	0.000111	0.000148	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000109	0.000146	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000109	0.000146	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—YAP1—polycystic ovary syndrome	0.000109	0.000145	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—LHB—polycystic ovary syndrome	0.000106	0.000142	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—NAMPT—polycystic ovary syndrome	0.000105	0.00014	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000104	0.000139	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000104	0.000139	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000103	0.000138	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000103	0.000137	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—GAB1—polycystic ovary syndrome	0.000102	0.000136	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000101	0.000134	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.0001	0.000134	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	9.99e-05	0.000134	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	9.99e-05	0.000134	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NAMPT—polycystic ovary syndrome	9.92e-05	0.000132	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	9.76e-05	0.00013	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	9.61e-05	0.000128	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	9.52e-05	0.000127	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	9.29e-05	0.000124	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	9.26e-05	0.000124	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	9.26e-05	0.000124	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	9.25e-05	0.000124	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	9.11e-05	0.000122	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	9.08e-05	0.000121	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	8.97e-05	0.00012	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	8.97e-05	0.00012	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	8.64e-05	0.000115	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—TH—polycystic ovary syndrome	8.31e-05	0.000111	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	8.31e-05	0.000111	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	8.26e-05	0.00011	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	8.2e-05	0.00011	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	8.14e-05	0.000109	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	8.09e-05	0.000108	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	8.09e-05	0.000108	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	7.9e-05	0.000106	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	7.9e-05	0.000106	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	7.8e-05	0.000104	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	7.75e-05	0.000103	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	7.72e-05	0.000103	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IL6—polycystic ovary syndrome	7.71e-05	0.000103	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	7.66e-05	0.000102	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.63e-05	0.000102	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	7.63e-05	0.000102	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	7.6e-05	0.000102	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PRL—polycystic ovary syndrome	7.31e-05	9.77e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.23e-05	9.66e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	7.04e-05	9.4e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	6.88e-05	9.19e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	6.78e-05	9.07e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	6.66e-05	8.9e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	6.62e-05	8.84e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—TH—polycystic ovary syndrome	6.6e-05	8.82e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	6.46e-05	8.64e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	6.42e-05	8.58e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	6.28e-05	8.38e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	6.13e-05	8.19e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	6.13e-05	8.19e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NCOR1—polycystic ovary syndrome	6.13e-05	8.19e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	6.03e-05	8.06e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NRG1—polycystic ovary syndrome	6.01e-05	8.03e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	5.99e-05	8e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	5.94e-05	7.93e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	5.72e-05	7.65e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	5.71e-05	7.63e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	5.5e-05	7.35e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.47e-05	7.31e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	5.43e-05	7.26e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MTHFR—polycystic ovary syndrome	5.41e-05	7.23e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.39e-05	7.2e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	5.39e-05	7.2e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	5.34e-05	7.13e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IRS2—polycystic ovary syndrome	5.15e-05	6.88e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	5.13e-05	6.86e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	5.13e-05	6.85e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	5.09e-05	6.8e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	5.05e-05	6.75e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	4.86e-05	6.5e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	4.64e-05	6.2e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	4.63e-05	6.19e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—POMC—polycystic ovary syndrome	4.57e-05	6.1e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—INS—polycystic ovary syndrome	4.54e-05	6.07e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	4.54e-05	6.06e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	4.53e-05	6.06e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IRS1—polycystic ovary syndrome	4.5e-05	6.01e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	4.39e-05	5.87e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—TH—polycystic ovary syndrome	4.37e-05	5.84e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—INS—polycystic ovary syndrome	4.31e-05	5.75e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	4.25e-05	5.68e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKT2—polycystic ovary syndrome	4.16e-05	5.56e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	4.04e-05	5.4e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	4e-05	5.34e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	3.96e-05	5.28e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.92e-05	5.23e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.78e-05	5.04e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	3.68e-05	4.91e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.63e-05	4.85e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—POMC—polycystic ovary syndrome	3.63e-05	4.85e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—INS—polycystic ovary syndrome	3.61e-05	4.82e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.58e-05	4.79e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	3.57e-05	4.77e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	3.4e-05	4.54e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.38e-05	4.52e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.33e-05	4.45e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	3.22e-05	4.3e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	3e-05	4.01e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.88e-05	3.85e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.8e-05	3.75e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.64e-05	3.52e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2.44e-05	3.25e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	2.4e-05	3.21e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—INS—polycystic ovary syndrome	2.39e-05	3.19e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.35e-05	3.14e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.24e-05	2.99e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.12e-05	2.84e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.98e-05	2.65e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6—polycystic ovary syndrome	1.88e-05	2.51e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.61e-05	2.15e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.58e-05	2.12e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.58e-05	2.1e-05	CbGpPWpGaD
